Cooper Companies | COO - Stammkapital

Aktienkurs
64.42
Täglich Wechseln
-0.53 -0.82%
Monatlich
-9.84%
Jährlich
-20.36%
Q2 Prognose
63.04




Stammkapital Veränderung Datum
Abbott USD 1.74B 23.39B 2025-09
Align Technology USD 71.75M 736K 2025-12
AtriCure USD 49.7M 10K 2025-09
Avanos Medical USD 46.46M 39.46K 2025-12
Bausch Health Companies USD 370.53M 59K 2025-12
Baxter International USD 514.28M 168.72M 2025-12
Bayer EUR 982.42M 0 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 195.1M 3.71M 2025-12
Dentsply International USD 199.5M 196.5M 2025-09
Dexcom USD 384.8M 5.2M 2025-12
Edwards Lifesciences USD 580.7M 0 2025-12
Globus Medical USD 135.06M 449K 2025-12
Haemonetics USD 46.83M 82K 2025-12
Inogen USD 23K 0 2023-12
Insulet USD 70.35M 1000 2025-12
Integra LifeSciences USD 77.89M 34K 2025-12
Intuitive Surgical USD 355.17M 674K 2026-03
J&J USD 2.41B 1.74M 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Merit Medical Systems USD 59.29M 72K 2025-09
Novartis USD 1.91B 10.64M 2025-12
ResMed USD 145.97M 25K 2025-12
STAAR Surgical USD 49.4M 49K 2025-12
Steris USD 98.15M 344K 2025-12
Stryker USD 382.4M 93K 2025-12
Tandem Diabetes Care USD 68.29M 518K 2025-12
Teleflex USD 44.19M 1000 2025-12
Utah Medical Products USD 3.19M 3.15M 2025-12
Zimmer Biomet Holdings USD 198.18M 18.44K 2025-12